Loading the company…
Loading the company…
Families: Kidney stone management, Bronchoscopy & lung nodule, Hysterectomy, hysteroscopy & ablation.
All companies · Product and company coverage
In the last ten years FDA made 11 decisions for Shanghai Anqing Medical Instrument (510(k) clearances, De Novo grants, PMA approvals and supplements) under the product codes MedaRep maps to 3 procedure families, the most in 2025 (4). The latest was on 2026-02-26.
| Family | Decisions on record |
|---|---|
| Kidney stone management | 6 |
| Bronchoscopy & lung nodule | 3 |
| Hysterectomy, hysteroscopy & ablation | 2 |
| Date | Kind | Number | Device |
|---|---|---|---|
| 2026-02-26 | 510(k) | K254251 | InnovexView (GC146-17, GC150-20, GC155-23) |
| 2025-10-03 | 510(k) | K252806 | Flexible Suction Ureterorenoscope (US27G-12-EU, US27G-12-US, US33G-17-EU, US33G-17-US, US38G-20-EU, US38G-20-US.) |
| 2025-08-27 | 510(k) | K251752 | Flexible Bronchoscope (BS27U-12EU, BS27U-12US, BS38U-20EU, BS38U-20US) |
| 2025-05-29 | 510(k) | K243497 | Portable Video Processor (EA101), Flexible Bronchoscope BS41H-12EU, BS41H-12US, BS46H-17EU, BS50H-20EU, BS46H-17US, BS50H-20US, BS53H-22EU, BS53H-22US, BS55H-24EU, BS55H-24US, BS59H-28EU, BS59H-28US |
| 2025-04-11 | 510(k) | K243857 | Flexible Ureterorenoscope (US27F-12-EU; US27F-12-US) |
Decisions under the product codes mapped to the procedure families; devices filed under other codes are not here. Applicants are rolled up to Shanghai Anqing Medical Instrument.